CN Patent

CN1411373A — 制备来氟米特的新方法和新晶形的来氟米特

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2003-04-16 · 23y expired

What this patent protects

公开了新的III型来氟米特及其制备方法。本发明也提供了II型来氟米特的经济制备方法和从III型来氟米特制备I型来氟米特的方法。也公开了包含这种新结晶型物的药物组合物和制剂，及使用它们治疗类风湿性关节炎的方法。

USPTO Abstract

公开了新的III型来氟米特及其制备方法。本发明也提供了II型来氟米特的经济制备方法和从III型来氟米特制备I型来氟米特的方法。也公开了包含这种新结晶型物的药物组合物和制剂，及使用它们治疗类风湿性关节炎的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN1411373A
Jurisdiction
CN
Classification
—
Expires
2003-04-16
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.